Intraoperative cytological assessment of sentinel lymph nodes in gynecologic cancer: diagnostic accuracy and limitations
https://doi.org/10.21294/1814-4861-2025-24-5-72-80
Abstract
Background. Intraoperative assessment of sentinel lymph nodes (SLNs) in patients with gynecological malignancies plays a key role in staging the disease and determining the extent of surgery. Cytological examination, is a valuable alternative to frozen section analysis due to its accessibility, efficiency, and minimal tissue requirements.
Objective: to evaluate the sensitivity, specificity, and diagnostic accuracy of intraoperative cytological examination of SLNs in patients with early-stage endometrial and cervical cancers.
Material and Methods. The study included 172 patients with clinically stage I endometrial (n=120) and cervical (n=52) cancer, who underwent surgery at the Department of Gynecological Oncology of the Cancer Research Institute, Tomsk National Research Medical Center. All patients underwent intraoperative cytological examination of imprint smears taken from the cut surface of SLNs. The results were compared with subsequent standard histological and immunohistochemical analyses.
Results. In patients with endometrial cancer, the sensitivity and specificity of the cytological method were 93.4 % and 99.1 %, respectively. For cervical cancer, sensitivity was 50 % and specificity was 98 %. The overall diagnostic accuracy of intraoperative cytology in the cohort was 88 %. The main causes of false-negative and false-positive results were micrometastases, endosalpingiosis, and sinus histiocytic infiltration of lymph nodes.
Conclusion. Intraoperative cytological evaluation of SLNs is a simple, rapid, and highly specific method for detecting macrometastases in gynecological cancers. Despite its limited sensitivity in detecting micrometastases, the method may be effectively used for intraoperative decision-making, particularly in resource-limited settings.
Keywords
About the Authors
O. V. PankovaRussian Federation
Olga V. Pankova - DSc, Senior Researcher, Department of General and Molecular Pathology, Cancer Research Institute. Researcher ID (WOS): C-8216-2012. Author ID (Scopus): 6603043604.
5, Kooperativny St., Tomsk, 634009
S. V. Vtorushin
Russian Federation
Sergey V. Vtorushin - MD, DSc, Professor, Deputy Director for Research and Translational Medicine, Head of Department of General and Molecular Pathology, Cancer Research Institute, TNRMC, Russian Academy of Sciences; Professor, Pathology Department, Siberian SMU, Ministry of Health of Russia (Tomsk, Russia). Researcher ID (WOS): S-3789-2016. Author ID (Scopus): 26654562300.
5, Kooperativny St., Tomsk, 634009; 2, Moskovsky trakt, Tomsk, 634050
M. V. Klimova
Russian Federation
Marina V. Klimova - MD, PhD, Clinical Laboratory Diagnostics, Department of General and Molecular Pathology, Cancer Research Institute.
5, Kooperativny St., Tomsk, 634009
D. S. Pismenny
Russian Federation
Dmitry S. Pismenny - MD, PhD, Clinical Laboratory Diagnostics, Department of General and Molecular Pathology, Cancer Research Institute, TNRMC, Russian Academy of Sciences; Associate Professor, Department of Pathological Anatomy, Siberian SMU, Ministry of Health of Russia (Tomsk, Russia). Author ID (Scopus): 57218625147.
5, Kooperativny St., Tomsk, 634009; 2, Moskovsky trakt, Tomsk, 634050
M. O. Ochirov
Russian Federation
Maksim O. Ochirov - MD, PhD, Researcher, Cancer Research Institute, Tomsk National Research Medical Center, Russian Academy of Sciences (Tomsk, Russia). Researcher ID (WOS): K-1722-2017. Author ID (Scopus): 57204634789.
5, Kooperativny St., Tomsk, 634009
L. A. Kolomiets
Russian Federation
Larisa A. Kolomiets - MD, DSc, Professor, Head of Gynecological Oncology Department, Cancer Research Institute, TNRMC, Russian Academy of Sciences; Professor, Department of Oncology, Siberian SMU, Ministry of Health of Russia. Researcher ID (WOS): C-8573-2012. Author ID (Scopus): 7004921120.
5, Kooperativny St., Tomsk, 634009; 2, Moskovsky trakt, Tomsk, 634050
V. M. Perelmuter
Russian Federation
Vladimir M. Perelmuter - MD, DSc, Professor, Chief Researcher, Department of General and Molecular Pathology, Cancer Research Institute, Researcher ID (WOS): C-8227-2012. Author ID (Scopus): 8091317300.
5, Kooperativny St., Tomsk, 634009
References
1. Petropoulou T., Kapoula A., Mastoraki A., Politi A., SpanidouKarvouni E., Psychogios I., Vassiliou I., Arkadopoulos N. Imprint cytology versus frozen section analysis for intraoperative assessment of sentinel lymph node in breast cancer. Breast Cancer (Dove Med Press). 2017; 9: 325–30. doi: 10.2147/BCTT.S130987.
2. Gao Y., Monaco S.E., Katz R.L., Zhang Y.H. Introduction of the WHO reporting system for lymph node cytopathology. J Clin Transl Pathol. 2024; 4(1): 36–43. doi: 10.14218/JCTP.2023.00044.
3. Hashmi A.A., Naz S., Ahmed O., Yaqeen S.R., Afzal A., Asghar I.A., Irfan M., Faridi N. Diagnostic accuracy of intraoperative touch imprint cytology for the diagnosis of axillary sentinel lymph node metastasis of breast cancer: comparison with intraoperative frozen section evaluation. Cureus. 2021; 13(1): e12960. doi: 10.7759/cureus.12960.
4. Abe M., Yamada T., Nakano A. Prospective comparison of intraoperative touch imprint cytology and frozen section histology on axillary sentinel lymph nodes in early breast cancer patients. Acta Cytol. 2020; 64: 492–97. doi: 10.1159/000508016.
5. Guo Y., Sun L., Chen X., Wen Q., Shao Z., Tang X., Shi X., Wang J., Zhang .Y, Zhu T. A multicenter noninferior randomized controlled study of sentinel lymph node biopsy alone versus sentinel lymph node biopsy plus lymphadenectomy for patients with stage I endometrial cancer, INSEC trial concept. BMC Cancer. 2023; 23(1): 1184. doi: 10.1186/s12885-023 -11226-1.
6. Clarke D., Leung E., Chachlani N., Rowlands D., Simon J., Hero I., England D. Intraoperative assessment of sentinel node using imprint cytology. World J Surg. 2010; 34(1): 55–61. doi: 10.1007/s00268-0090301-2.
7. Abad-Licham M., Astigueta J., De Las Casas L., Gonzales-Saravia J., Ortiz C., Vásquez O., Bardales R.H. Intraoperative cytology when cryostat is not available. A 7‐year experience in a Peruvian cancer center. Diagn Cytopathol. 2023; 51(2): 45–53. doi: 10.1002/dc.25062.
8. Layfield D., Agrawal A., Roche H., Cutress R. Intraoperative assessment of sentinel lymph nodes in breast cancer. Br J Surg. 2011; 98(1): 4–17. doi: 10.1002/bjs.7229.
9. Ahuja S., Yadav P., Fattahi-Darghlou M., Zaheer S. Comparison of Intraoperative Imprint Cytology versus Frozen Section for Sentinel Lymph Node Evaluation in Breast Cancer. A study along with Systematic Review and Meta-analysis of literature. Asian Pac J Cancer Prev. 2024; 25(4): 1113–19. doi: 10.31557/APJCP.2024.25.4.1113.
10. Volchenko N.N., Borisova O.V., Melnikova V.Yu., Ermolaeva A.G., Glukhova Yu.K. Urgent intraoperative cytological examination of sentinel lymph nodes in early breast cancer. Oncology. Journal named after P.A. Hertzen. 2019; 8(3): 169–74. (in Russian). doi: 10.17116/onkolog20198031169. EDN: NZWTCX.
11. Starkova M.V., Zikiryakhodzhaev A.D., Grushina T.I., Slavnova E.N., Glukhova Yu.K., Surkova V.S., Leontiev A.V. Urgent cytological examination in sentinel lymph node diagnostics in breast cancer patients. News of Clinical Cytology. 2019; 23(3): 15–21. (in Russian). doi: 10.24411/1562-4943-2019-10302. EDN: TUNDYB.
12. Tew K., Irwig L., Matthews A., Crowe P., Macaskill P. Metaanalysis of sentinel node imprint cytology in breast cancer. Br J Surg. 2005; 92(9): 1068–80. doi: 10.1002/bjs.5139.
13. Yang Q.Q., Hu Y.G., Hu C.H., Han Y.T., Shen H.Y. The diagnostic accuracy of touch imprint cytology for sentinel lymph node metastases of breast cancer: an up-to-date meta-analysis of 4,073 patients. Open Med (Wars). 2023; 18(1): 20230827. doi: 10.1515/med-2023-0827.
14. Touhami O., Trinh X.B., Gregoire J., Sebastianelli A., Renaud M.C., Grondin K., Plante M. Predictors of non-sentinel lymph node (non-SLN) metastasis in patients with sentinel lymph node (SLN) metastasis in endometrial cancer. Gynecol Oncol. 2015; 138(1): 41–45. doi: 10.1016/j.ygyno.2015.04.008.
15. Rossi E.C., Kowalski L.D., Scalici J., Cantrell L., Schuler K., Hanna R.K., Method M., Ade M., Ivanova A., Boggess J.F. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017; 18(3): 384–92. doi: 10.1016/S1470-2045(17)30068-2.
16. Chong Y., Park G., Cha H.J., Kim H.J., Kang C.S., Abdul-Ghafar J., Lee S.S. A stepwise approach to fine needle aspiration cytology of lymph nodes. J Pathol Transl Med. 2023; 57(4): 196–207. doi: 10.4132/jptm.2023.06.12.
17. Cui Q., Dai L., Li J., Xue J. Accuracy of CEUS-guided sentinel lymph node biopsy in early-stage breast cancer: a study review and metaanalysis. World J Surg Oncol. 2020; 18(1): 112. doi: 10.1186/s12957020-01890-z.
Review
For citations:
Pankova O.V., Vtorushin S.V., Klimova M.V., Pismenny D.S., Ochirov M.O., Kolomiets L.A., Perelmuter V.M. Intraoperative cytological assessment of sentinel lymph nodes in gynecologic cancer: diagnostic accuracy and limitations. Siberian journal of oncology. 2025;24(5):72-80. (In Russ.) https://doi.org/10.21294/1814-4861-2025-24-5-72-80








































